Why Shares of Aurora Cannabis Continue to See Such Extreme Volatility

: ACB | Aurora Cannabis Inc. News, Ratings, and Charts

ACB – It’s been quite a week for shares of Aurora Cannabis (ACB). In just the past few days of trading, the stock was trading for just over $5 per share and has been as high as $19.

 

It’s been quite a week for shares of Aurora Cannabis (ACB). In just the past few days of trading, the stock was trading for just over $5 per share and has been as high as $19.  Currently the stock is trading just below $16.

Investors might be curious as to what is causing so much volatility.

ACB initiated a 12-for-1 reverse stock split last week after facing a delisting warning from the New York Stock Exchange, due to their share price being below $1 per share. 

Then on May 14th, ACB posted its third-quarter earnings.  They saw revenues jumping 35% from their previous quarter, which caused their shares to have a major rally.

On Monday of this week Ladenburg Thalmann reiterated their buy rating on shares of Aurora Cannabis but analyst Glenn Mattson lowered his price target to $18 per share. The firm originally had a $36 split-adjusted price target prior to the update. 

Mattson said, “We think ACB can become a solid cash flow generator simply from the Canadian operations and, with a strong market position in Canada, the company can create significant value from here based on this one market. We do think that it will look to expand into the U.S. but not until federal legality is more clear.” 

Short-sellers have been capitalizing on the downtrend in ACB for some time now but were caught by surprise with this earnings release.  As a result, short-sellers covering their trades have played a large part in this dramatic rally.

Next quarter should ultimately determine the future for ACB.  We will be watching closely for further write-downs along with how efficient that is in terms of SG&A cost-cutting. ACB has promised a profitable Q1 2021 quarter due to their debt covenants so this really needs to happen if ACB wants to maintain shareholder confidence.

(Disclosure: The author is long ACB)

Want More Great Investing Ideas?

9 “BUY THE DIP” Growth Stocks for 2020

7 “Safe-Haven” Dividend Stocks for Turbulent Times

REVISED 2020 Stock Market Outlook– Discover why there is more downside ahead and the Top 10 picks for the bear market.

 

 


ACB shares were trading at $15.42 per share on Tuesday afternoon, down $1.68 (-9.82%). Year-to-date, ACB has declined -40.51%, versus a -7.72% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
ACBGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

How to Beat the Market the Rest of the Year?

The easy gains that came at the start of this new bull market are fading away fast. In fact the stock market (SPY) has become quite volatile with gains harder to come by. Gladly there are solutions as will be shared in this commentary to get you on the right path to outperform the market through the end of 2021 and beyond. Read the rest below...

:  |  News, Ratings, and Charts

2022 Stock Market Outlook

The stock market (SPY) has continued on a bullish path in 2021. Will that continue in 2022? And what could happen to awaken the bear market from hibernation? 40 year investment veteran Steve Reitmeister explores this and more in this early edition of his 2022 Stock Market Outlook. Read on for full details below...

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

:  |  News, Ratings, and Charts

3 Value Stocks to Buy While You Still Can

After outperforming from last fall into the spring, value stocks have been overtaken by growth stocks, but that is expected to change as the economic recovery continues. So, now is the time to start putting your money to work in undervalued companies that offer the potential for strong returns such as Gilead Sciences Inc. (GILD), HP Inc. (HPQ), and CNH Industrial N.V. (CNHI).

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

Read More Stories

More Aurora Cannabis Inc. (ACB) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ACB News